Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
06/2010
06/09/2010EP2194044A1 Quinolone derivative
06/09/2010EP2193121A1 Quinolin-4-one and 4-oxodihydrocinnoline derivatives as inhibitors of poly(adp-ribose)polymerase (parp)
06/09/2010EP1472213B1 Process for the synthesis of n-acyl-2-amino-4-alkoxy-5-nitrobenzoic acids
06/09/2010CN1919525B Quinolinols as fluxing and accelerating agents for underfill compositions
06/09/2010CN101730684A sulfonyl-quinoline derivatives
06/09/2010CN101723935A 1,5-diaryl-substituted 2,4-dienone derivative as well as preparation method and application thereof
06/09/2010CN101723921A CaSR antagonist
06/09/2010CN101723894A N-quinoline amide derivatives and preparation method and application thereof
06/09/2010CN101723893A 2,3-disubstituted-2,3-dihydro quinoline ketone chiral compound as well as preparation method and application thereof
06/09/2010CN101723854A Preparation method of 6-substituted amino-3-cyano quinoline compound and midbody thereof
06/09/2010CN101302195B Novel synthetic method of 7-hydroxy-3,4-dihydroquinolines
06/09/2010CN101177412B Method for synthesizing acetyl substituted nitrogen heterocycle compounds
06/08/2010US7732614 2,6-quinolinyl derivatives, processes for preparing them and their uses
06/08/2010US7732613 Met kinase inhibitors
06/08/2010US7732612 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones
06/08/2010US7732611 Amine salt of carbostyril derivative
06/08/2010US7732600 Quinoline and quinazoline derivatives having affinity for 5HT1-type receptors
06/08/2010US7732146 Method for screening an agent that modulates activity of macrophage migration inhibitory factor
06/03/2010WO2010062506A2 Decahydro-1h-indenoquinolinone and decahydro-3h-cyclopentaphenanthridinone cyp17 inhibitors
06/03/2010WO2010060228A1 Enantioselective synthesis of asymmetric beta-carboline intermediates
06/03/2010WO2010060214A1 Hybrid -ionone and curcumin molecules as anticancer agents
06/03/2010US20100137361 Tetrahydro-Quinolinylurea Derivatives
06/03/2010US20100137329 Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the faah enzyme
06/03/2010US20100137300 Indolizine Acetic Acid Derivatives as CRTH2 Antagonists
06/03/2010US20100137290 Oxazolidinone antibiotic derivatives
06/03/2010US20100135906 In vivo imaging of sulfotransferases
06/03/2010CA2744360A1 Hybrid -ionone and curcumin molecules as anticancer agents
06/03/2010CA2739251A1 Decahydro-1h-indenoquinolinone and decahydro-3h-cyclopentaphenanthridinone cyp17 inhibitors
06/02/2010EP2192124A1 Transition metal complex and process for producing conjugated aromatic compound with the transition metal complex
06/02/2010EP1326833B1 Substituted heterocyclic compounds for treating multidrug resistance
06/02/2010CN201493101U Heating device of melamine fluidized bed reactor
06/02/2010CN101717366A Use of coordination polymer as electron transport material
06/02/2010CN101348463B Synthetic method of argatroban and intermediate thereof
06/01/2010US7728150 N-[3-(1-Ethyl-5-fluoro-indan-1-yl)-1H-indol-7-yl]-methanesulfonamide; for treating congestive heart disease, hypertension, and atherosclerosis
06/01/2010US7728143 Salt and crystalline forms thereof of a drug
06/01/2010US7728142 3-methanesulfonylquinolines as GABAB enhancers
06/01/2010US7728007 Therapeutic amides
06/01/2010US7728005 such as N-(2-bromophenyl)-N'-[2-(4-fluorophenoxy)ethyl]urea, having superior antiinflammatory and analgesic activity
06/01/2010US7727997 N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives
06/01/2010US7727980 Tricyclic androgen receptor modulator compounds and methods
05/2010
05/27/2010WO2010059633A2 Compounds for treating parasitic disease
05/27/2010WO2010058995A1 Electroluminescent device using the electroluminescent compounds
05/27/2010WO2010058314A1 Hydroxyquinolin-2(1h)-ones and derivatives thereof
05/27/2010WO2010057922A1 Curable composition comprising a thermolatent base
05/27/2010US20100130745 Process for the preparation of optically active ethenylphenyl alcohols
05/27/2010US20100130737 Regulating Agent of GPR34 Receptor Function
05/27/2010US20100130546 Quinolone compound and pharmaceutical composition
05/27/2010US20100130545 Bridged six-membered ring compounds
05/27/2010US20100129471 Iso ca-4 and analogues thereof as potent cytotoxic agents inhibiting tubuline polymerization
05/27/2010US20100127618 Indenochrysene derivative and organic light-emitting device using same
05/27/2010CA2743903A1 Compounds for treating parasitic disease
05/26/2010EP2189439A2 CaSR antagonist
05/26/2010EP2188260A1 Therapeutic quinoline and naphthalene derivatives
05/26/2010EP2188259A1 Method of making and administering quinoline derivatives as anti-cancer agents
05/26/2010EP1730103B1 Formamide derivatives useful as adrenoceptor
05/26/2010CN1956961B Stable crystal form of 4-oxoquinoline compound
05/26/2010CN1910153B Derivatives of pyridine and quinoline
05/26/2010CN1910137B Aryl aniline derivatives as beta2 adrenergic receptor agonists
05/26/2010CN1849117B Entry inhibitors of the HIV virus
05/26/2010CN1642580B Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands
05/26/2010CN1520702B Electroluminescent irisium compounds with fluorinated phenylpyridines, phenylpyridines and phenylquinolines and device made with such compounds
05/26/2010CN1391469B Npyy5拮抗剂 Npyy5 antagonist
05/26/2010CN101715441A Quinoline derivatives as CRTH2 receptor ligands
05/26/2010CN101190895B N-[(3S)-1,2,3,4-tetrahydroisoquinolino-3-formacyl]amino acid, preparation method and application thereof
05/26/2010CN101058564B Aryl alkyl carbamate derivatives production and use thereof in therapy
05/25/2010US7723525 Chemokine-binding heterocyclic compound salts, and methods of use thereof
05/25/2010US7723524 8-cyanoquinolonecarboxylic acid derivative
05/25/2010US7723519 high binding efficiencies between D3 and D2 dopaminergic receptor subtypes; drug abuse, drug dependence
05/25/2010US7723380 Tetrahydrofuro[2,3-b]furyl carbamates containing an (oxy)hydrazide group; these compounds target the HIV protease in both wild type and mutant strains of HIV.
05/25/2010US7723357 Thalidomide and thalidomide derivatives for treating spinal disorders mediated by nucleus pulposus
05/25/2010CA2593381C Processes for producing 7-isoindolinequinolonecarboxylic acid derivatives and intermediates therefor, salts of 7-isoindolinequinolonecarboxylic acids, hydrates thereof, and compositions containing the same as active ingredient
05/25/2010CA2412543C Process for the preparation of quinoline derivatives
05/25/2010CA2393951C Method for preparing quinoline-5,8-diones
05/20/2010WO2010057101A2 Compounds useful as hiv blockers
05/20/2010WO2010056960A1 Methods of preparing quinoline derivatives
05/20/2010WO2010056865A1 Quinoline derivatives as ion channel modulators
05/20/2010WO2010056549A1 Pyridine, bicyclic pyridine and related analogs as sirtuin modulators
05/20/2010US20100125091 Substituted heterocyclic compounds as ion channel modulators
05/20/2010US20100125090 Modulators of ATP-Binding Cassette Transporters
05/20/2010US20100124545 Cyclic carboxamide compounds and analogues thereof as of hepatitis c virus
05/20/2010CA2743416A1 Methods of preparing quinoline derivatives
05/20/2010CA2742297A1 Pyridine, bicyclic pyridine and related analogs as sirtuin modulators
05/19/2010EP2185542A2 Substituted quinoline derivatives as h1 receptor antagonists
05/19/2010EP2185520A1 Fungicidal 2-alkylthio-2-quinolinyloxy-acetamide derivatives
05/19/2010EP2185519A2 Novel fungicides
05/19/2010EP2185518A2 Saturated and insaturated bi- or tricyclic aryloxyacetamide derivatives and their use as fungicides
05/19/2010EP2185517A1 Process for preparing a leukotriene antagonist and an intermediate thereof
05/19/2010CN101139319B Substituted quinoline trimer indene derivative and method for making same
05/19/2010CN101058616B Crosslinking polymer containing cavity transmission unit of 8-hydroxyquinoline metal complex and preparation method
05/18/2010US7718814 6-(2,4-dinitrophenylazo)-2,5,7,8-tetramethyltridecyl))-1,2,3,4-tetrahydroquinoline; to treat cell proliferative diseases
05/18/2010US7718806 Process for production of carbostyril compound
05/18/2010US7718805 Process for preparing rebamipide
05/18/2010US7718804 Quaternary nitrogen heterocyclic boronic acid-containing compounds sensitive to glucose and fructose; contact lens; radiometers; kits; ophthalmic sensors
05/18/2010US7718704 Immunosuppressant compounds and compositions
05/18/2010US7718702 Cannabinoid receptor ligands
05/18/2010US7718650 Piperazino or diazepino-substituted arylsulfonamides; obesity, type II diabetes and/or central nervous system disorders; 4-chloro-N-[5-(4-methyl-1,4-diazepan-1-yl)-2-nitrophenyl]benzenesulfonamide for example; Serotonin 5-HT6 receptor antagonist activity
05/18/2010CA2442713C Method for preparing 7-quinolinyl-3,5-dihydroxyhept-6-enoate
05/18/2010CA2304204C Quinoline-containing .alpha.-ketoamide cysteine and serine protease inhibitors
05/14/2010WO2010054052A1 Compositions and methods of sirt activation
05/14/2010WO2010053210A1 Indenopyrene compound and organic light-emitting device using the compound
1 ... 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 ... 277